Funding
← Back to your selection

Goldman Sachs Alternatives Life Sciences

Activity from announced rounds

Activity in this selectionsimplyhealth-ventures-98030ada
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$189M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection
Third Arc Bio

Develops novel multifunctional antibodies for oncology and immunology & inflammation indications

$52MSeries A+
Role not disclosed